Related Experiment Videos
Cytokine system as potential target for antipsoriatic therapy
1Department of Dermatology, Albert Szent-Györgyi Medical University, Szeged, Hungary.
Experimental Dermatology
|February 1, 1994
Summary
Cytokines are key in psoriasis pathogenesis, driving inflammation and skin cell overgrowth. Treatments for this skin condition target the cytokine network to reduce these effects.
Area of Science:
- Immunology
- Dermatology
- Cell Biology
Background:
- Cytokines are signaling molecules with diverse functions, produced by various cells.
- Growing evidence implicates cytokines in the development of psoriasis and other skin diseases.
- Altered cytokine networks contribute to inflammatory cell accumulation and epidermal hyperplasia in psoriatic lesions.
Purpose of the Study:
- To review the role of the cytokine network in psoriasis pathogenesis.
- To examine how cytokines contribute to inflammatory cell infiltration and epidermal hyperproliferation in psoriatic skin.
- To discuss the impact of common psoriasis therapies on the cytokine system.
Main Methods:
- Literature review of current knowledge on cytokines in psoriasis.
- Analysis of the mechanisms by which cytokines influence skin inflammation and proliferation.
- Examination of the effects of therapeutic agents on cytokine production and receptors.
Main Results:
- The cytokine network is significantly altered in psoriatic lesions, promoting inflammation and hyperplasia.
- Cytokines orchestrate the recruitment of inflammatory cells to the skin.
- Therapeutic compounds modulate cytokine production and/or receptor activity to achieve clinical improvement.
Conclusions:
- Cytokines are central to the pathogenesis of psoriasis.
- Targeting the cytokine network is a key strategy for psoriasis treatment.
- Understanding cytokine modulation by therapies explains their efficacy in managing psoriatic disease.